Bias pervades the scientific reporting of animal studies

July 17, 2013

A new study published in the open access journal PLOS Biology suggests that the scientific literature could be compromised by substantial bias in the reporting of animal studies, and may be giving a misleading picture of the chances that potential treatments could work in humans.

Testing a new therapeutic intervention (such as a drug or surgical procedure) on human subjects is expensive, risky and ethically complex, so the vast majority are first tested on animals. Unfortunately, cost and constrain the size of animal studies, giving them limited statistical power, and as a result the scientific literature contains many studies that are either uncertain in their outcomes or contradictory. A way around this limitation has been to conduct a "meta-analysis": scientists collect data from a large number of published studies on the same intervention, combine them using sophisticated statistical methods, and then end up with a much more solid basis on which to decide whether to proceed with human clinical trials.

In the new study, Konstantinos Tsilidis, John Ioannidis and colleagues at Stanford University examined 160 previously published meta-analyses of animal studies looking at potential treatments for a range of serious human neurological disorders (, stroke, Parkinson's disease, Alzheimer's disease and injury). These meta-analyses covered 1000 original published animal studies comparing more than 4000 sets of . The authors' "meta-analysis of meta-analyses" used the most precise study in each meta-analysis as an estimate of the true effect size of a particular treatment. It then asked whether the expected number of studies had statistically significant conclusions. Alarmingly, the authors found that more than twice as many studies as expected appeared to reach statistical significance.

The authors suggest that rather than reflecting wilful fraud on the part of the scientists who conduct the original studies, this "excess significance bias" comes from two main sources. One is that scientists conducting an animal study tend to choose the method of data analysis that appears to give them the "better" result. The second arises because scientists usually want to publish in higher profile journals; such journals tend to strongly prefer studies with positive, rather than negative, results. Many studies with negative results are not even submitted for publication or, if submitted, either cannot get published or are published belatedly in low-visibility journals, reducing their chances of inclusion in a meta-analysis.

It is likely that the types of bias reported in the new PLOS Biology paper have been responsible for the inappropriate promotion of treatments from animal studies into human clinical trials. It also seems unlikely that this phenomenon is confined to studies of neurological disorders; rather this is probably a general feature of the reporting of animal studies.

The authors suggest several remedies for the bias that they have observed. First, animal studies should adhere to strict guidelines (such as the ARRIVE guidelines) for study design and analysis. Second, animal studies (like human clinical trials) should be pre-registered so that publication of the outcome, however negative, is ensured. Third, availability of methodological details and raw data would make it easier for other scientists to verify published studies.

Explore further: Potential neurological treatments often advance to clinical trials on shaky evidence, study says

More information: Tsilidis KK, Panagiotou OA, Sena ES, Aretouli E, Evangelou E, et al. (2013) Evaluation of Excess Significance Bias in Animal Studies of Neurological Diseases. PLoS Biol 11(7): e1001609. doi:10.1371/journal.pbio.1001609

Related Stories

Potential neurological treatments often advance to clinical trials on shaky evidence, study says

July 16, 2013
Clinical trials of drug treatments for neurological diseases such as Alzheimer's and Parkinson's often fail because the animal studies that preceded them were poorly designed or biased in their interpretation, according to ...

Improving systematic reviews of animal studies will help translational medicine

July 16, 2013
Many new developments and initiatives have been introduced to improve the quality and translational value of animal research, and must continue with support from the wider scientific community. These are the conclusions of ...

Meta-analysis helps psychologists build knowledge

January 9, 2012
(Medical Xpress) -- When scientists want to know the answer to a question that’s been studied a great deal, they conduct something called a meta-analysis, pooling data from multiple studies to arrive at one combined ...

Statin use linked to reduced risk of hepatocellular cancer

February 12, 2013
(HealthDay)—Statin use is associated with a reduced risk of hepatocellular carcinoma (HCC), most strongly in Asian populations, according to a meta-analysis published in the February issue of Gastroenterology.

Serum iron levels may be causally associated with Parkinson's disease risk

June 4, 2013
Increased iron levels may be causally associated with a decreased risk of developing Parkinson's disease, says a new paper published this week in PLOS Medicine. Irene Pichler from EURAC in Italy and a group of international ...

Delayed skin closure may reduce surgical infection

June 30, 2013
(HealthDay)—Delayed primary skin closure may reduce the risk of infection after surgery, but the current studies are not definitive due to poor design, according to the results of a meta-analysis published online June 26 ...

Recommended for you

Sugar industry withheld evidence of sucrose's health effects nearly 50 years ago

November 21, 2017
A U.S. sugar industry trade group appears to have pulled the plug on a study that was producing animal evidence linking sucrose to disease nearly 50 years ago, researchers argue in a paper publishing on November 21 in the ...

Female researchers pay more attention to sex and gender in medicine

November 7, 2017
When women participate in a medical research paper, that research is more likely to take into account the differences between the way men and women react to diseases and treatments, according to a new study by Stanford researchers.

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.